Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 2/20 | 1.00 |
| ▸ | APP | P05067 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | MEN1 | O00255 | 6/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | MPI | P34949 | 1/20 | 0.50 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11311746 | 0.98 | TERT (0.96) | TERTAPPALDH1A1MEN1KMT2A | |
| SCHEMBL15423130 | 0.85 | TERT (0.74) | TERTAPPALDH1A1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL17975809 | 0.85 | TERT (0.74) | TERTAPPALDH1A1MEN1KMT2A | |
| SCHEMBL29727898 | 0.83 | TERT (0.70) | TERTAPPALDH1A1MEN1KMT2A | |
| SCHEMBL29727902 | 0.83 | TERT (0.70) | TERTAPPALDH1A1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL28730611 | 0.80 | TERT (0.67) | TERTALDH1A1MEN1KMT2AMAPT | |
| Hydrochloric Acid SCHEMBL2475899 | 0.79 | TERT (0.65) | TERTAPPALDH1A1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL11310524 | 0.79 | TERT (0.65) | TERTAPPALDH1A1KMT2AKDM4E | |
| SCHEMBL29522572 | 0.79 | TERT (0.63) | TERTAPPALDH1A1MEN1KMT2A | |
| Formaldehyde SCHEMBL28589504 | 0.79 | TERT (0.64) | TERTAPPALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250345446-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | DRAUPNIR BIO APS (DK) | 2025-11-13 | — | — | US | disclosed |
| EP-4543858-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | Draupnir Bio ApS (DK) | 2025-04-30 | — | — | EP | disclosed |
| US-20240013878-A1 | Machine learning methods for classification and clinical detection of Bevacizumab responsive glioblastoma subtypes based on microRNA (miRNA) biomarkers | SHI JIAN (US) | 2024-01-11 | — | — | US | disclosed |
| WO-2023247754-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | DRAUPNIR BIO APS (DK) | 2023-12-28 | — | — | WO | disclosed |
| US-11600045-B2 | Collaborative light show authoring for tessellated geometries | CONTRAVENTUM, LLC (US) | 2023-03-07 | — | — | US | disclosed |
| US-20220366648-A1 | Collaborative Light Show Authoring for Tessellated Geometries | CONTRAVENTUM, LLC (US) | 2022-11-17 | — | — | US | disclosed |
| US-11282276-B2 | Collaborative light show authoring for tessellated geometries | CONTRAVENTUM, LLC (US) | 2022-03-22 | — | — | US | disclosed |
| US-5045440-A | Pentaethylenehexamine, phthalocyanines, improved durability | HOECHST CELANESE CORP. (US) | 1991-09-03 | — | — | US | disclosed |
| WO-1991012610-A2 | STABILIZATION OF OPTICAL INFORMATION STORAGE MEDIA BY INCORPORATION OF NITROGEN CONTAINING COMPOUNDS | HOECHST CELANESE CORPORATION (US) | 1991-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250345446-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | SORT1, SCARB1, LAMP1 | TERT 4828/4885APP 2213/4885ALDH1A1 3836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.